$CLYM
Climb Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$10.86
▲+1.40%+$0.150
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateClimb Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CLYM up today? It is at $10.86 (+1.40%), and our scanner flagged it 74 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CLYM spikes, and full due diligence on CLYM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CLYM 74 times in the last 30 days. Create a free account to track $CLYM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
CLYM is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on CLYM today, peaking at 9.8x its normal volume.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 30, 2026 · 8 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
9,165,903 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $10.91/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ra Capital Management, L.P. Director | Other | 70K 0.1% of company | added 0.7% | 10.13M | $90K at $1.29 | Sep 28, 26 |
Thomas Stephen Basil Director | Sold (automatic/other) | -100K 0.2% of company | sold 18% | 468K | $1.4M at $13.67 | Sep 15, 26 |
Brennan Aoife Officer | Sold (automatic/other) | -31K 0.05% of company | sold 26% | 88K | $407K at $13.17 | Jun 29, 26 |
Brennan Aoife Officer | Other | 69K 0.1% of company | added 100% | 119K | n/a | Jun 27, 26 |
Thomas Stephen Basil Director | Sold (automatic/other) | -16K 0.03% of company | sold 9.5% | 155K | $114K at $7.01 | Feb 26, 26 |
Thomas Stephen Basil Director | Sold (automatic/other) | -34K 0.06% of company | sold 16% | 171K | $236K at $7.00 | Feb 25, 26 |
Thomas Stephen Basil Director | Sold (automatic/other) | -10K 0.02% of company | sold 4.7% | 205K | $58K at $5.81 | Feb 13, 26 |
Thomas Stephen Basil Director | Sold (automatic/other) | -90K 0.2% of company | sold 30% | 215K | $471K at $5.23 | Feb 12, 26 |
Ra Capital Management, L.P. Director | Bought (open market) | +7K 0.01% of company | added <0.1% | 11.30M | $25K at $3.50 | Jan 5, 26 |
Ra Capital Management, L.P. Director | Bought (open market) | +101K 0.2% of company | added 0.9% | 11.29M | $290K at $2.86 | Dec 12, 25 |
Ra Capital Management, L.P. Director | Sold (automatic/other) | -20.44M 35.6% of company | sold 87% | 3.08M | n/a | Dec 11, 25 |
Ra Capital Management, L.P. Director | Bought (open market) | +213K 0.4% of company | added 6.9% | 3.29M | $465K at $2.18 | Dec 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
CLYM is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on CLYM today, peaking at 9.8x its normal volume.
CLYM last traded at $10.86, up 1.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Climb Bio, Inc. Common Stock (CLYM) is next expected to report earnings on Thursday, November 5, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CLYM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLYM 74 times in the last 30 days.
CLYM (Climb Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $624M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLYM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CLYM discussion
Sign in to ask a question or join the discussion.